In another type of mesenchymal tumour, osteosarcoma, syndecan-2 expression is reduced compared to that in osteoblasts and osteocytes in normal bone, and the expression of the proteoglycan sensitises tumour cells to basal and chemotherapy-induced apoptosis [23], [24]. Here, SDC2 is linked to neoplasm.